Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical

Drug Metabolism and Disposition

Volumn 26, Issue 2, 1998, Pages 185-187

  Lown, Kenneth S ^b   Ghosh, Mita ^b   Watkins, Paul B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; CYTOCHROME P450; DNA FRAGMENT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CATALYSIS; DNA DETERMINATION; DNA SEQUENCE; DRUG ABSORPTION; DRUG METABOLISM; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; ENZYMES; HUMANS; INTESTINES; LIVER; MIXED FUNCTION OXYGENASES; SEQUENCE ANALYSIS, DNA;

EID: 0031952956     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS and Guengerich FP (1986) Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci USA 83:8064-8068.
2. Chiu SH (1993) The use of in vitro metabolism studies in the understanding of new drugs. J Pharmacol Toxicol Methods 29:77-83.
3. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
4. de Waziers I, Cugnenc PH, Yang CS, Leroux JP and Beaune PH (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferase in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387-394.
5. Fitzsimmons ME and Collins JM (1997) Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug Metab Dispos 25:256-266.
6. Gan LS, Moseley MA, Khosla B, Augustijns PF, Bradshaw TP, Hendren RW and Thakker DR (1996) CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. Drug Metab Dispos 24:344-349.
7. Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwick JP, Meyer UA, Gelboin HV and Idle JR (1988) Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 7:79-86.
8. Hebert MF, Roberts JP, Prueksaritanont T and Benet LZ (1993) Clinical evidence of metabolic differences between intestinal and hepatic cytochrome P450. Clin Pharmacol Ther 53:190.
9. Hsing S, Gatmaitan Z and Arias IM (1992) The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 102:879-885.
10. Kolars JC, Awni WM, Merion RM and Watkins PB (1991) First-pass metabolism of cyclosporin by the gut. Lancet 338:1488-1490.
11. Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C and Watkins PB (1992) Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 90:1871-1878.
12. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W and Watkins PB (1997a) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545-2553.
13. Lown KS, Kolars JC, Ghosh M, Schmiedlin-Ren P and Watkins PB (1996) Induction of MDR1 expression in normal rat and human intestine in vivo. Gastroenterology 110:A344.
14. Lown KS, Mayo RR, Leichtman AB, Hsiao H-L, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ and Watkins PB (1997b) Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporin A. Clin Pharmacol Ther, 62:248-60.
15. Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G. Parker GA and Guzelian PS (1986) Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci USA 83:5311-5315.
16. Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS and Thummel KE (1996) First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 60:14-24.
17. Saitoh H and Aungst BJ (1995) Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm Res 12:1304-1310.
18. Sanger F, Nicklen S and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
19. Schuetz EG, Furuya KN and Schuetz JD (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275:1011-1018.
20. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
21. Wacher VJ, Wu C-Y and Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129-134. [/shcom]